INHIBITION OF CYP1A, CYP2B, AND CYP3A ACTIVITIES BY 5HT3 ANTAGONISTS

被引：0
作者：
GAN, LS [1 ]
BOEHLERT, C [1 ]
THAKKER, D [1 ]
SERABJITSINGH, C [1 ]
机构：
[1] GLAXO RES INST,DEPT DRUG METAB,RES TRIANGLE PK,NC 27709
来源：
FASEB JOURNAL | 1994年 / 8卷 / 07期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1248 / A1248
页数：1
相关论文
共 50 条
  • [21] Co-treatment with indole-3-carbinol and resveratrol modify porcine CYP1A and CYP3A activities and expression
    Zamaratskaia, Galia
    Thogersen, Rebekka
    Candek-Potokar, Marjeta
    Rasmussen, Martin Kroyer
    XENOBIOTICA, 2018, 48 (03) : 232 - 240
  • [22] Sex difference in induction of hepatic CYP2B and CYP3A subfamily enzymes by nicardipine and nifedipine in rats
    Konno, Y
    Sekimoto, M
    Nemoto, K
    Degawa, M
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 196 (01) : 20 - 28
  • [23] Development of in vitro higher throughput CYP1A, CYP2B6 and CYP3A induction assays using probe cocktail approach
    Yu, Jingjing
    Tang, Jun
    DRUG METABOLISM REVIEWS, 2009, 41 : 87 - 87
  • [24] Effects of inhibitors of CYP1A and CYP2B on styrene metabolism in mouse liver and lung microsomes
    Carlson, GP
    Hynes, DE
    Mantick, NA
    TOXICOLOGY LETTERS, 1998, 98 (03) : 131 - 137
  • [25] Humanized CYP3A Mice: (2) Functional Expression of Human CYP3A Isoforms in CYP3A-HAC Mice and Inhibition of CYP3A via Mechanism-Based Inactivation
    Watanabe, Mio
    Aueviriyavit, Sasitorn
    Kobayashi, Kaoru
    Iuchi, Nahoko
    Kazuki, Yasuhiro
    Oshimura, Mitsuo
    Chiba, Kan
    DRUG METABOLISM REVIEWS, 2010, 42 : 30 - 31
  • [26] Effect of CYP3A5 genotype on the extent of CYP3A inhibition by verapamil.
    Wang, Y
    Jin, Y
    Hilligoss, JK
    Ho, H
    Hamman, MA
    Hu, Z
    Gorski, JC
    Hall, SD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P3 - P3
  • [27] The roles of CYP3A and CYP2B isoforms in hepatic bioactivation and detoxification of the pyrrolizidine alkaloid senecionine in sheep and hamsters
    Huan, JY
    Miranda, CL
    Buhler, DR
    Cheeke, PR
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1998, 151 (02) : 229 - 235
  • [28] Quantitative structure-activity relationship study of binding affinity of azole compounds with CYP2B and CYP3A
    Itokawa, Daisuke
    Nishioka, Tomoki
    Fukushima, Junji
    Yasuda, Tomoyo
    Yamauchi, Aiko
    Chuman, Hiroshi
    QSAR & COMBINATORIAL SCIENCE, 2007, 26 (07): : 828 - 836
  • [29] Dose response relationship for CYP1A and CYP3A in primary cultures of beagle dog hepatocytes
    Graham, RA
    Czerwinski, M
    Hamilton, G
    Thompson, TN
    Parkinson, A
    LeCluyse, EL
    DRUG METABOLISM REVIEWS, 2003, 35 : 124 - 124
  • [30] OMEPRAZOLE AND LANSOPRAZOLE ARE MIXED INDUCERS OF CYP1A AND CYP3A IN HUMAN HEPATOCYTES IN PRIMARY CULTURE
    CURIPEDROSA, R
    DAUJAT, M
    PICHARD, L
    OURLIN, JC
    CLAIR, P
    GERVOT, L
    LESCA, P
    DOMERGUE, J
    JOYEUX, H
    FOURTANIER, G
    MAUREL, P
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 269 (01) : 384 - 392
12345